Filgrastim (r-metHuG-CSF) in the 21st Century: SD/01

Overview

Journal Acta Haematol

Specialty Hematology

Date 2001 Jul 21

PMID 11463988

Citations 6

Authors

G Morstyn

M A Foote

T Walker

G Molineux

Affiliations

Soon will be listed here.

Abstract

SD/01, a sustained-duration molecule, has been developed by adding a poly [ethylene glycol] molecule to the filgrastim molecule. The pegylation does not change the properties of filgrastim, except that the plasma clearance is decreased and plasma half-life is increased. Increasing the duration of the biological effects of filgrastim may offer certain groups of patients better benefits. Early clinical studies have been encouraging with no serious toxicities noted.

Citing Articles

Site-selective fatty acid chain conjugation of the N-terminus of the recombinant human granulocyte colony-stimulating factor.

Wang X, Su Z, Du J, Yu W, Sun W Front Bioeng Biotechnol. 2024; 12:1360506.

PMID: 38576447 PMC: 10993259. DOI: 10.3389/fbioe.2024.1360506.

The effectiveness and safety of same-day versus next-day administration of long-acting granulocyte colony-stimulating factors for the prophylaxis of chemotherapy-induced neutropenia: a systematic review.

Lyman G, Allcott K, Garcia J, Stryker S, Li Y, Reiner M Support Care Cancer. 2017; 25(8):2619-2629.

PMID: 28484882 DOI: 10.1007/s00520-017-3703-y.

Chemotherapy continuity and incidence of febrile neutropenia with CHOP therapy in an outpatient setting.

Usami E, Kimura M, Iwai M, Takenaka S, Teramachi H, Yoshimura T Mol Clin Oncol. 2016; 4(4):591-596.

PMID: 27073670 PMC: 4812315. DOI: 10.3892/mco.2016.738.

The practical management of treatment failure in chronic hepatitis C: a summary of current research and management options for refractory patients.

Hassanein T, Shiffman M, Zein N Gastroenterol Hepatol (N Y). 2013; 3(6 Suppl 20):4-32.

PMID: 23329897 PMC: 3099312.

Repeated lentivirus-mediated granulocyte colony-stimulating factor administration to treat canine cyclic neutropenia.

Yanay O, Dale D, Osborne W Hum Gene Ther. 2012; 23(11):1136-43.

PMID: 22845776 PMC: 3498882. DOI: 10.1089/hum.2012.045.